Con­tract man­u­fac­tur­ers BioCi­na and Genezen name new CEOs

A pair of CD­MOs are bring­ing in new CEOs.

Tak­ing the helm at BioCi­na is Mark Wom­ack. Ac­cord­ing to his LinkedIn pro­file, Wom­ack has been in lead­er­ship po­si­tions at sev­er­al con­tract man­u­fac­tur­ers. His ca­reer spans more than 30 years, in­clud­ing roles such as CEO of the con­tract man­u­fac­tur­er KBI Bio­phar­ma and Se­lex­is SA. Be­fore that, he was CEO of Stelis Bio­phar­ma and chief busi­ness of­fi­cer of Seat­tle-based man­u­fac­tur­er AGC Bi­o­log­ics.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER